![logo](/logos/SANOFI.NS.webp)
Sanofi India Limited
NSE:SANOFI.NS
7,351.45 (INR) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Sanofi India Limited |
Symbool | SANOFI.NS |
Munteenheid | INR |
Prijs | 7,351.45 |
Beurswaarde | 169,303,893,500 |
Dividendpercentage | 2.03% |
52-weken bereik | 5,892.8 - 10,525 |
Industrie | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Mr. Rodolfo Hrosz |
Website | https://www.sanofiindialtd.com |
An error occurred while fetching data.
Over Sanofi India Limited
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singaporem and internationally. It provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, central nervous system, anti-infective, epilepsy, allergy and vitamins, anti-histamines, and minerals and supplements under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Targocid,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)